Over 13,000 more get jabs vs COVID-19 in Angeles City | Inquirer News

Over 13,000 more get jabs vs COVID-19 in Angeles City

/ 11:37 AM July 09, 2021

vaccine vaccination covid-19

INQUIRER.net stock photo

ANGELES CITY, Pampanga––Some 13,804 frontline personnel in essential sectors have received their first dose of COVID-19 vaccines, the city government reported Thursday, July 8.

The city said it had fully inoculated 268 workers in essential institutions and establishments.

ADVERTISEMENT

As of July 8, the city government said 55,120 priority individuals had been inoculated with the first dose, while 10,768 had been double jabbed.

FEATURED STORIES

It said 35,303 doses of the Sinovac vaccine, 21,513 of AstraZeneca, and 9,360 of Pfizer had been administered to the residents.

On July 8, this city recorded 28 new COVID-19 cases, 15 recoveries, and zero deaths.

A total of 6,772 infections were registered here since the start of the pandemic last year, of which 365 remained active and 6,107 had recovered. The death toll was at 300.

The highly commercialized village of Balibago has 35 active COVID-19 cases. Barangay Pampang has the second-highest active cases at 31, followed by Malabanias with 27. INQ

LZB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Angeles City, COVID-19, Pampanga, Regions, Vaccines

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.